Srb Corp Gilead Sciences, Inc. Transaction History

Srb Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $34,363 - $38,969	469 Added 7.6%	6,636 $537,000
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $42,811 - $46,707	579 Added 10.36%	6,167 $462,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $100,941 - $115,137	1,328 Added 31.17%	5,588 $430,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $329,340 - $375,220	4,260 New	4,260 $353,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.02 Million - $1.16 Million	-17,081 Reduced 72.26%	6,558 $404,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $169,465 - $190,869	2,936 Added 14.18%	23,639 $1.46 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $187,049 - $212,304	-2,883 Reduced 12.22%	20,703 $1.5 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $1.6 Million - $1.72 Million	23,586 New	23,586 $1.65 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $411,971 - $517,982	-6,634 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $93,897 - $109,032	-1,298 Reduced 16.36%	6,634 $510,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $496,781 - $636,305	7,932 New	7,932 $593,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $438,919 - $482,796	-7,123 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $19,440 - $21,459	-311 Reduced 4.18%	7,123 $451,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $459,941 - $515,770	7,434 New	7,434 $502,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

Stay updated on Srb Corp with notifications on news.